Zoetis Inc (NYSE:ZTS) has been given a consensus rating of “Hold” by the seventeen analysts that are covering the firm. Three research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, nine have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $56.94.
A number of research analysts recently issued reports on the company. Zacks Investment Research raised Zoetis from a “sell” rating to a “hold” rating in a report on Friday, March 17th. Craig Hallum assumed coverage on Zoetis in a report on Wednesday, March 15th. They issued a “buy” rating and a $65.00 price target for the company. BMO Capital Markets reaffirmed an “outperform” rating and issued a $60.00 price target on shares of Zoetis in a report on Sunday, February 19th. Guggenheim lifted their price target on Zoetis from $60.00 to $65.00 and gave the company a “buy” rating in a report on Thursday, February 16th. Finally, Off Wall Street reaffirmed a “strong sell” rating and issued a $35.00 price target on shares of Zoetis in a report on Thursday, February 16th.
Several hedge funds have recently made changes to their positions in ZTS. Credit Agricole S A boosted its stake in shares of Zoetis by 12.3% in the fourth quarter. Credit Agricole S A now owns 401,625 shares of the company’s stock worth $21,499,000 after buying an additional 44,138 shares during the period. Envestnet Asset Management Inc. boosted its stake in shares of Zoetis by 29.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 82,109 shares of the company’s stock worth $4,394,000 after buying an additional 18,832 shares during the period. HighTower Advisors LLC boosted its stake in shares of Zoetis by 1.9% in the third quarter. HighTower Advisors LLC now owns 187,077 shares of the company’s stock worth $9,726,000 after buying an additional 3,564 shares during the period. DnB Asset Management AS boosted its stake in shares of Zoetis by 0.7% in the third quarter. DnB Asset Management AS now owns 274,007 shares of the company’s stock worth $14,251,000 after buying an additional 1,900 shares during the period. Finally, State of Tennessee Treasury Department boosted its stake in shares of Zoetis by 60.2% in the third quarter. State of Tennessee Treasury Department now owns 162,791 shares of the company’s stock worth $8,467,000 after buying an additional 61,153 shares during the period. 94.54% of the stock is owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/2486030/zoetis-inc-zts-receives-56-94-consensus-price-target-from-analysts.html.
Shares of Zoetis (NYSE:ZTS) traded down 0.18% during mid-day trading on Tuesday, hitting $54.19. 2,124,663 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $53.47 and a 200-day moving average price of $52.49. The company has a market capitalization of $26.66 billion, a price-to-earnings ratio of 32.84 and a beta of 1.07. Zoetis has a 52 week low of $45.28 and a 52 week high of $56.50.
Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, February 16th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.02. Zoetis had a return on equity of 72.96% and a net margin of 14.10%. The business earned $1.30 billion during the quarter, compared to analysts’ expectations of $1.28 billion. During the same period in the previous year, the business posted $0.43 earnings per share. The firm’s revenue for the quarter was up .2% compared to the same quarter last year. On average, equities analysts anticipate that Zoetis will post $2.32 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 1st. Stockholders of record on Thursday, April 6th will be paid a $0.105 dividend. The ex-dividend date is Tuesday, April 4th. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.78%. Zoetis’s dividend payout ratio (DPR) is presently 30.44%.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc and related companies with MarketBeat.com's FREE daily email newsletter.